Skip to content
Clinical Trials for Alzheimer's Disease

Nashville, Tennessee

Alzheimer's disease clinical trials in Nashville, TN

10 Alzheimer's disease studies are recruiting participants at sites in Nashville as of November 16, 2026, according to ClinicalTrials.gov. Clinical Trials for Alzheimer's Disease can help you understand your options and connect with a study team.

Call (888) 927-5895
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Nashville at a glance

  • 10 studies are recruiting at a site in Nashville.
  • By phase: Phase 2 (5), Phase 3 (2), Observational (3).
  • By sponsor: industry (5), university, hospital or other (5).
  • Most recent update to one of these records: November 16, 2026.

Studies recruiting in Nashville

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

    • Phase 3
    • Ages 50 to 90
    • All sexes
    Sponsor
    Hoffmann-La Roche
    Study site
    K2 Medical Research - Nashville
    Registry record
    NCT07177352 · updated
  2. Tennessee Alzheimer's Project

    • Observational
    • Ages 60 and older
    • All sexes
    Sponsor
    Vanderbilt University Medical Center
    Study site
    Vanderbilt University Medical Center
    Registry record
    NCT05372172 · updated
  3. A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

    • Phase 3
    • Ages 55 to 90
    • All sexes
    Sponsor
    Karuna Therapeutics, Inc., a Bristol Myers Squibb company
    Study site
    Vanderbilt Psychiatric Hospital
    Registry record
    NCT06585787 · updated
  4. Alzheimer's Tau Platform: Master Protocol

    • Phase 2
    • Ages 50 to 80
    • All sexes
    Sponsor
    Paul S. Aisen
    Study site
    Vanderbilt University Medical Center
    Registry record
    NCT06957418 · updated
  5. Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease

    • Phase 2
    • Ages 55 to 80
    • All sexes
    Sponsor
    Lighthouse Pharmaceuticals, Inc.
    Study site
    K2 Medical Research Nashville LLC
    Registry record
    NCT06847321 · updated
  6. Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

    • Phase 2
    • Ages 55 to 90
    • All sexes
    Sponsor
    Celgene
    Study site
    Vanderbilt University Medical Center- Village
    Registry record
    NCT06808984 · updated
  7. Randomized Study to Evaluate the Effect of Obicetrapib in Participants With Preclinical Alzheimer's Disease

    • Phase 2
    • Ages 55 to 85
    • All sexes
    Sponsor
    NewAmsterdam Pharma
    Study site
    K2 Medical Research
    Registry record
    NCT07794670 · updated
  8. Cholinergic Integrity in Down Syndrome in Association With Aging, Alzheimer's Disease Pathology, and Cognition

    • Phase 2
    • Ages 18 to 55
    • All sexes
    Sponsor
    Vanderbilt University Medical Center
    Study site
    Vanderbilt University Medical Center Clinical Research Center
    Registry record
    NCT05231798 · updated
  9. Trial-Ready Cohort-Down Syndrome (TRC-DS)

    • Observational
    • Ages 25 to 55
    • All sexes
    Sponsor
    University of Southern California
    Study site
    Vanderbilt University Medical Center Center for Cognitive Medicine
    Registry record
    NCT04165109 · updated
  10. Swallowing Impairments in Adults With and Without Alzheimer's Disease

    • Observational
    • Ages 60 and older
    • All sexes
    Sponsor
    Vanderbilt University Medical Center
    Study site
    Vanderbilt University Medical Center
    Registry record
    NCT06678100 · updated

Source: ClinicalTrials.gov. Data processed . See every Alzheimer's disease study recruiting in Nashville, TN on ClinicalTrials.gov.

Ask about studies near Nashville

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Clinical Trials for Alzheimer's Disease does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-5895

or send a short form

How should we reach you?

Call